Cirurgia de Estômago e Duodeno

Reconstrução em Y de Roux vs. Billroth-I após gastrectomia distal para câncer gástrico.

20 Set, 2021 | 13:39h

Roux‐en‐Y versus Billroth‐I reconstruction after distal gastrectomy for gastric cancer – Cochrane Library

---

Incidência e mortalidade globais do câncer gástrico, 1980-2018.

13 Ago, 2021 | 11:55h

Global Incidence and Mortality of Gastric Cancer, 1980-2018 – JAMA Network Open

---

Ranitidina absolvida? Estudo do FDA mostra que a ranitidina não é convertida ao carcinógeno NDMA, independentemente da dieta.

12 Jul, 2021 | 11:23h

Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial – JAMA

Editorial: Ranitidine and Risk of N-Nitrosodimethylamine (NDMA) Formation

Comentário: Ranitidine: FDA finds no evidence of elevated NDMA, regardless of diet

 

Comentário no Twitter

Despite ranitidine (zantac) being pulled from market last year, a new study from the FDA did not find evidence that it increases concentrations of the carcinogenic metabolite people were worried about (i.e., it's probably safe). From @JAMA_current https://t.co/AdRic2GdXS

— Zack Williams (@QuantPsychiatry) June 28, 2021

In this crossover, randomized clinical trial, oral ranitidine did not significantly increase 24-hour urinary excretion of NDMA when administered with a noncured-meats diet or a cured-meats diet. https://t.co/EszRvfJOFJ

— JAMA (@JAMA_current) June 28, 2021

 

---